# Aptera Motors Corp: financial statements, quarterly

SEV · Nasdaq · CIK 1786471 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sev.md) · [Financials](/companies/sev/financials.md) · [Filings](/companies/sev/filings.md) · [Insiders](/companies/sev/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sev/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $m | not reported | not reported | [5.3](/filings/0001493152-25-023455.md) | [5.3 d](/filings/0001493152-26-013581.md) | [3.2](/filings/0001493152-26-022732.md) | [5.9](/filings/0001493152-26-037373.md) | [4.7](/filings/0001493152-25-023455.md) | [7.5 d](/filings/0001493152-26-013581.md) | [5.9](/filings/0001493152-26-022732.md) | [7.1](/filings/0001493152-26-037373.md) |
| Selling, general and administrative | $m | not reported | not reported | [3.1](/filings/0001493152-25-023455.md) | [4.7 d](/filings/0001493152-26-013581.md) | [7.9](/filings/0001493152-26-022732.md) | [8.0](/filings/0001493152-26-037373.md) | [3.2](/filings/0001493152-25-023455.md) | [7.6 d](/filings/0001493152-26-013581.md) | [4.4](/filings/0001493152-26-022732.md) | [4.1](/filings/0001493152-26-037373.md) |
| Operating income | $m | not reported | not reported | [(8.3)](/filings/0001493152-25-023455.md) | [(10.0) d](/filings/0001493152-26-013581.md) | [(11.2)](/filings/0001493152-26-022732.md) | [(13.9)](/filings/0001493152-26-037373.md) | [(7.9)](/filings/0001493152-25-023455.md) | [(15.1) d](/filings/0001493152-26-013581.md) | [(10.3)](/filings/0001493152-26-022732.md) | [(11.2)](/filings/0001493152-26-037373.md) |
| Net income | $m | [(12.2)](/filings/0001493152-25-023455.md) | [(5.6)](/filings/0001493152-25-023455.md) | [(8.2)](/filings/0001493152-25-023455.md) | [(8.9) d](/filings/0001493152-26-013581.md) | [(10.9)](/filings/0001493152-26-037373.md) | [(12.1)](/filings/0001493152-26-037373.md) | [(5.5)](/filings/0001493152-25-023455.md) | [(15.5) d](/filings/0001493152-26-013581.md) | [(10.2)](/filings/0001493152-26-037373.md) | [(10.9)](/filings/0001493152-26-037373.md) |
| Diluted EPS | $ per share | not reported | not reported | [(0.35)](/filings/0001493152-25-023455.md) | not reported | [(0.46)](/filings/0001493152-26-022732.md) | [(0.52)](/filings/0001493152-26-037373.md) | [(0.23)](/filings/0001493152-25-023455.md) | not reported | [(0.32)](/filings/0001493152-26-022732.md) | [(0.30)](/filings/0001493152-26-037373.md) |
| Basic EPS | $ per share | not reported | not reported | [(0.35)](/filings/0001493152-25-023455.md) | not reported | [(0.46)](/filings/0001493152-26-022732.md) | [(0.52)](/filings/0001493152-26-037373.md) | [(0.23)](/filings/0001493152-25-023455.md) | not reported | [(0.32)](/filings/0001493152-26-022732.md) | [(0.30)](/filings/0001493152-26-037373.md) |

- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [13.2](/filings/0001493152-26-013581.md) | not reported | not reported | [12.0](/filings/0001493152-25-023455.md) | [9.6](/filings/0001493152-26-037373.md) | [17.7](/filings/0001493152-26-022732.md) | [10.1](/filings/0001493152-26-037373.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [14.4](/filings/0001493152-26-013581.md) | not reported | not reported | [15.2](/filings/0001493152-25-023455.md) | [10.1](/filings/0001493152-26-037373.md) | [18.2](/filings/0001493152-26-022732.md) | [11.9](/filings/0001493152-26-037373.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [34.9](/filings/0001493152-26-013581.md) | not reported | not reported | [34.9](/filings/0001493152-25-023455.md) | [30.2](/filings/0001493152-26-037373.md) | [39.0](/filings/0001493152-26-022732.md) | [32.4](/filings/0001493152-26-037373.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [6.6](/filings/0001493152-26-013581.md) | not reported | not reported | [7.0](/filings/0001493152-25-023455.md) | [9.5](/filings/0001493152-26-037373.md) | [8.1](/filings/0001493152-26-022732.md) | [7.1](/filings/0001493152-26-037373.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [8.0](/filings/0001493152-26-013581.md) | not reported | not reported | [7.7](/filings/0001493152-25-023455.md) | [9.8](/filings/0001493152-26-037373.md) | [9.3](/filings/0001493152-26-022732.md) | [8.0](/filings/0001493152-26-037373.md) |
| Shareholders' equity | $m | [24.7](/filings/0001493152-26-013581.md) | [27.5](/filings/0001493152-25-023455.md) | [29.1](/filings/0001493152-25-023455.md) | [31.2](/filings/0001493152-25-023455.md) | [26.9](/filings/0001493152-26-037373.md) | [23.3](/filings/0001493152-26-037373.md) | [26.8](/filings/0001493152-26-037373.md) | [27.2](/filings/0001493152-25-023455.md) | [20.4](/filings/0001493152-26-037373.md) | [29.6](/filings/0001493152-26-037373.md) | [24.4](/filings/0001493152-26-037373.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(5,584) d](/filings/0001493152-26-013581.md) | [(3,559)](/filings/0001493152-26-022732.md) | [(3,572) d](/filings/0001493152-26-037373.md) | [(3,777) d](/filings/0001493152-25-023455.md) | [(4,350) d](/filings/0001493152-26-013581.md) | [(7,890)](/filings/0001493152-26-022732.md) | [(8,050) d](/filings/0001493152-26-037373.md) |
| Capital expenditure | $k | [196 d](/filings/0001493152-26-013581.md) | [10.0](/filings/0001493152-26-022732.md) | [20.0 d](/filings/0001493152-26-037373.md) | [740 d](/filings/0001493152-25-023455.md) | [664 d](/filings/0001493152-26-013581.md) | [39.0](/filings/0001493152-26-022732.md) | [163 d](/filings/0001493152-26-037373.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.2](/filings/0001493152-25-023455.md) | [23.4](/filings/0001493152-26-022732.md) | [23.4](/filings/0001493152-26-037373.md) | [23.6](/filings/0001493152-25-023455.md) | [32.1](/filings/0001493152-26-022732.md) | [36.8](/filings/0001493152-26-037373.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,560,115 at 2026-08-06, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037373.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.